Cocrystal Pharma Statistics
Total Valuation
COCP has a market cap or net worth of $20.61 million. The enterprise value is $19.78 million.
| Market Cap | 20.61M |
| Enterprise Value | 19.78M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026, before market open.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
COCP has 19.26 million shares outstanding. The number of shares has increased by 28.73% in one year.
| Current Share Class | 19.26M |
| Shares Outstanding | 19.26M |
| Shares Change (YoY) | +28.73% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 38.18% |
| Owned by Institutions (%) | 5.79% |
| Float | 11.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 61.88 |
| Forward PS | n/a |
| PB Ratio | 14.00 |
| P/TBV Ratio | 19.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 59.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 1.28.
| Current Ratio | 1.24 |
| Quick Ratio | 1.11 |
| Debt / Equity | 1.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -311.68% and return on invested capital (ROIC) is -134.79%.
| Return on Equity (ROE) | -311.68% |
| Return on Assets (ROA) | -96.07% |
| Return on Invested Capital (ROIC) | -134.79% |
| Return on Capital Employed (ROCE) | -497.29% |
| Weighted Average Cost of Capital (WACC) | 11.64% |
| Revenue Per Employee | $33,000 |
| Profits Per Employee | -$993,800 |
| Employee Count | 10 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.30% in the last 52 weeks. The beta is 1.48, so COCP's price volatility has been higher than the market average.
| Beta (5Y) | 1.48 |
| 52-Week Price Change | -12.30% |
| 50-Day Moving Average | 1.11 |
| 200-Day Moving Average | 1.11 |
| Relative Strength Index (RSI) | 39.38 |
| Average Volume (20 Days) | 47,466 |
Short Selling Information
The latest short interest is 322,748, so 1.68% of the outstanding shares have been sold short.
| Short Interest | 322,748 |
| Short Previous Month | 322,544 |
| Short % of Shares Out | 1.68% |
| Short % of Float | 2.71% |
| Short Ratio (days to cover) | 5.72 |
Income Statement
In the last 12 months, COCP had revenue of $330,000 and -$9.94 million in losses. Loss per share was -$0.76.
| Revenue | 330,000 |
| Gross Profit | -5.76M |
| Operating Income | -10.11M |
| Pretax Income | -9.94M |
| Net Income | -9.94M |
| EBITDA | -10.06M |
| EBIT | -10.11M |
| Loss Per Share | -$0.76 |
Balance Sheet
The company has $2.17 million in cash and $1.34 million in debt, with a net cash position of $828,000 or $0.04 per share.
| Cash & Cash Equivalents | 2.17M |
| Total Debt | 1.34M |
| Net Cash | 828,000 |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 1.04M |
| Book Value Per Share | 0.08 |
| Working Capital | 620,000 |
Cash Flow
In the last 12 months, operating cash flow was -$7.95 million and capital expenditures -$12,000, giving a free cash flow of -$7.97 million.
| Operating Cash Flow | -7.95M |
| Capital Expenditures | -12,000 |
| Depreciation & Amortization | 50,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -7.97M |
| FCF Per Share | -$0.41 |
Margins
| Gross Margin | n/a |
| Operating Margin | -3,063.64% |
| Pretax Margin | -3,011.52% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COCP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -28.73% |
| Shareholder Yield | -28.73% |
| Earnings Yield | -48.67% |
| FCF Yield | -39.01% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 11, 2022. It was a reverse split with a ratio of 1:12.
| Last Split Date | Oct 11, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
COCP has an Altman Z-Score of -109.08 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -109.08 |
| Piotroski F-Score | 1 |